Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
about
Influenza treatment and prophylaxis with neuraminidase inhibitors: a reviewPandemic Swine H1N1 Influenza Viruses with Almost Undetectable Neuraminidase Activity Are Not Transmitted via Aerosols in Ferrets and Are Inhibited by Human Mucus but Not Swine MucusInfluenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern VietnamResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirThe N-terminal fragment of a PB2 subunit from the influenza A virus (A/Hong Kong/156/1997 H5N1) effectively inhibits RNP activity and viral replicationNew millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.Molecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009-2011.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationRecombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex.Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.The early diversification of influenza A/H1N1pdm.Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assaysAssessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.OpenFluDB, a database for human and animal influenza virus.Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus.The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patientsNeuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virusComparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts.Fitness of neuraminidase inhibitor-resistant influenza A virusesComparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitorsThe pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks.Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.Effect of half-life on the pharmacodynamic index of zanamivir against influenza virus delineated by a mathematical modelImportance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza virusesSynthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase InhibitorsEconomic evaluations of neuraminidase inhibitors to control influenza.Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial.Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.
P2860
Q26860032-020F850F-99C7-4BC9-8AB0-C4E69D8BE17DQ28394728-799432E8-957A-4FD9-AC80-3BEA67A85E65Q28473743-4716FD65-632B-4442-A8EF-B59E80431296Q28535274-42C1A874-EA73-4C8C-AA89-D6339E3AA846Q28542440-985AB82B-EF95-4005-A2D9-DC827E73540BQ30332341-ABC831BE-BB9F-4994-B914-8BBE0605258AQ30354016-29FCD37C-A33B-4978-BE19-484DCC1162AEQ30364619-56BF9B55-FFE8-42FE-AA73-A4C99398DD89Q30374227-93DDE873-4053-4C8A-874F-18001244FB81Q30379353-91D11119-9F93-452B-8B81-31D381A5BAD8Q30382876-28A74C06-DB1A-4E69-B031-3C6F7446DF95Q30383545-A1B076BD-C11F-48CF-8703-F19E15BEA5F4Q30383771-7A938739-24F6-4518-88C6-1F52E4C93019Q30383816-15B75E09-D5A0-474C-96C1-BDC662D12988Q30386535-EA686865-E629-4A17-959C-E803B3D2B500Q30389713-F273C3D5-F12C-48F7-85DB-DCD5A7DCBA87Q30390818-4F8A2F3A-0E1D-4519-BD24-6BAF0BF13C9BQ30391319-078E30A0-6F1A-4DF0-A864-219ACC7AEDE0Q30392198-0FE33ED3-E657-4731-B34A-0EA6C905E9C0Q30393896-12189512-5806-4768-90FB-BA239F5DF4F8Q30397216-6D842919-3CF3-46F6-A536-3E85B008F1E7Q30400058-786B034F-659C-440E-8BFF-9D7D19069BD9Q30402866-F8410CAD-13DB-4C70-91AB-B946436FF892Q30414559-4466E90B-8734-46D1-B270-0EC1CD6A8957Q30419391-B5388622-F188-42A9-8695-DE67A3EC56D0Q30438033-5BD05F6F-3A5D-459F-B464-7BF3CC546E5BQ30438502-3DCA5EBA-30E5-4B9E-8FDD-E71361E73FC6Q30450742-08A40F8D-24EE-4F07-8BD6-37C525ADD984Q33614501-994D53F8-84E1-4A89-934C-B34845F3E56FQ34046111-129F1A02-DE90-4C7B-BA55-E304D3D1A496Q34077100-58152416-322B-460F-993B-6DA1C3248B3BQ34737693-1B35DA54-488E-424D-ABB0-6BA339EA0218Q35024169-75C71547-76D3-4D23-92D9-51690656C43CQ35040516-4127B6EC-24B8-47AA-A20E-5D479ABF3D74Q36020202-E4521E9C-2F35-448D-AE51-017C639951B5Q36509477-F5981203-80E3-4C63-AC32-050FF2923301Q36870919-D30EF560-A9A6-4037-81AB-A849E68ECD4DQ37074496-BF43CFE1-62C1-4DC1-9167-04D21203DD19Q37087113-15272861-A230-465F-993F-038F3B7AC1B7Q37146912-34289751-8430-469E-A736-F4AA813DA36E
P2860
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Detection of influenza virus r ...... by an enzyme inhibition assay.
@ast
Detection of influenza virus r ...... by an enzyme inhibition assay.
@en
type
label
Detection of influenza virus r ...... by an enzyme inhibition assay.
@ast
Detection of influenza virus r ...... by an enzyme inhibition assay.
@en
prefLabel
Detection of influenza virus r ...... by an enzyme inhibition assay.
@ast
Detection of influenza virus r ...... by an enzyme inhibition assay.
@en
P1433
P1476
Detection of influenza virus r ...... by an enzyme inhibition assay.
@en
P2093
Larisa V Gubareva
P356
10.1016/S0166-3542(01)00192-9
P577
2002-01-01T00:00:00Z